The North America dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.4% over the forecast period (2020-2026). The growth of the North America dipeptidyl peptidase 4 (DPP-4) inhibitors industry in the region is primarily driven by the increase in the number of cases of diabetes type 2 in the North […]